| Jul 24 2024 |
Senate Committee Will Hold Hearing on Understanding the Potential Environmental Impacts of 6PPD |
Bergeson & Campbell, P.C. |
| Jul 24 2024 |
Gary Chodes Joins The National Law Review as CEO |
The National Law Review / The National Law Forum LLC |
| Jul 24 2024 |
China on the Move: Breaking Barriers and Accelerating Growth: Clinical Trials, Drug Approvals, and Cross-Border Data Transfers in Biotech |
Greenberg Traurig, LLP |
| Jul 24 2024 |
Who is Paying Who: The Employee or the Employer? |
Nelson Mullins |
| Jul 24 2024 |
United States | New U.S. Global Music Ambassadors Visit New Zealand, Canada and South Korea |
Berry Appleman & Leiden |
| Jul 24 2024 |
FTC Noncompete Ban Rule Survives Challenge in Pennsylvania Federal Court, but Still Contested in Florida and Texas |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jul 24 2024 |
It’s a Cruel Summer (for Employers Still Facing Uncertainty of Looming Federal Trade Commission Noncompete Rule) |
Foley & Lardner LLP |
| Jul 24 2024 |
“Science-Washing” in the Beauty Industry: Marketing Do’s & Don’ts |
Foley & Lardner LLP |
| Jul 24 2024 |
Pennsylvania Court Keeps FTC Non-Compete Ban on Life Support |
Polsinelli PC |
| Jul 24 2024 |
The Chevron Doctrine: Part II—Congress’s Reaction to the Repeal and the Legislative Process |
Polsinelli PC |
| Jul 24 2024 |
Foley Automotive Update 24 July 2024 |
Foley & Lardner LLP |
| Jul 24 2024 |
Health Plan Hygiene Part 2: ERISA Fiduciaries – That May Mean You! |
Jackson Lewis P.C. |
| Jul 24 2024 |
Mid-Year 2024: Labor + Wage/Hour |
Jackson Lewis P.C. |
| Jul 24 2024 |
BRight Minds in Healthcare Delivery Episode 8: Innovation in Spine Health [Podcast] |
Blank Rome LLP |
| Jul 24 2024 |
What to Expect in a Post-Chevron World |
Strassburger McKenna Gutnick & Gefsky |
| Jul 24 2024 |
More Delta-8 THC Foods Target of FDA and FTC Enforcement |
ArentFox Schiff LLP |
| Jul 24 2024 |
DHS’ Second UFLPA Strategy Update: Aluminum, PVC, and Seafood Enter the UFLPA’s Purview for Scrutiny and Enforcement |
ArentFox Schiff LLP |
| Jul 24 2024 |
The Power of Social Proof: Building Trust Through Client Testimonials |
Stefanie Marrone Consulting |
| Jul 24 2024 |
Medicaid Overpayment Audits: What Medical Providers Need to Know |
Nelson Mullins |
| Jul 24 2024 |
Employment Law This Week Episode 353 - Spilling Secrets: Can FTC’s Non-Compete Ban Survive Without Chevron Deference? [Video, Podcast] |
Epstein Becker & Green, P.C. |
| Jul 24 2024 |
Dialysis and Deceptiveness: Whistleblower Earns $6.37 Million for Reporting Unlawful Kickbacks |
Tycko & Zavareei LLP |
| Jul 24 2024 |
U.S. Census Bureau Seeks Feedback on New Race and Ethnicity Data Collection Standards |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jul 24 2024 |
FTC Issues Orders to Eight Companies Seeking Information About Surveillance Pricing |
Hinch Newman LLP |
| Jul 23 2024 |
US Department of Commerce Issues Guidance Addressing Heightened Export Diversion Risks |
Hunton Andrews Kurth |
| Jul 23 2024 |
Pennsylvania Federal Court Refuses to Enjoin FTC’s Noncompete Rule, Creates Split in Federal Courts |
Squire Patton Boggs (US) LLP |
| Jul 23 2024 |
Mortgage Originators and Secondary Market Issuers Must Maintain AVM Quality Control Policies for Covered Securitization Determinations |
Hunton Andrews Kurth |
| Jul 23 2024 |
FCC to Consider Formal Rules for Use of Artificial Intelligence and Robocalls |
Squire Patton Boggs (US) LLP |
| Jul 23 2024 |
From Legislation to Innovation: The CHIPS Act and a New Era of Semiconductor Innovation |
Foley & Lardner LLP |
| Jul 23 2024 |
BETO’s Feedstock-Conversion Interface Consortium Intends to Issue Industrial Partnership Call in September 2024 |
Bergeson & Campbell, P.C. |
| Jul 23 2024 |
FTC Watchdog Monitors Competitive Implications of Surveillance Pricing |
Mintz |
| Jul 23 2024 |
Supreme Court Clarifies Arbitration Clauses: Key Takeaways for Companies |
Womble Bond Dickinson (US) LLP |
| Jul 23 2024 |
Does the Seventh Amendment Limit State Administrative Adjudication? |
Squire Patton Boggs (US) LLP |
| Jul 23 2024 |
CMS Proposes to Amend Overpayment Rule-Questions Remain Regarding How the Rule Will be Implemented Should CMS Adopt the False Claims Act’s “Reckless Disregard or Deliberate Ignorance” Standard |
Sheppard, Mullin, Richter & Hampton LLP |
| Jul 23 2024 |
FDA Revisits and Updates Guidance on Addressing Misinformation – Ten Years Later |
Sheppard, Mullin, Richter & Hampton LLP |
| Jul 23 2024 |
Non-Signatory Bound to an Agreement’s Arbitration Clause |
Foley & Lardner LLP |
